Packing-Line Improvement Based on a Fault-Tree Analysis Approach - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Packing-Line Improvement Based on a Fault-Tree Analysis Approach
This article focuses on upgrading and improving a packing process to comply with current good manufacturing practices. The authors sought to maintain proper quality assurance for finished products.

Pharmaceutical Technology
Volume 3, Issue 32

Figure 3: Packing-process fault tree showing the main start section and the major unwanted event.
A BP 4100 technical balance (Sartorius, Göttingen, Germany) with a 0–4100-g range and a resolution of ± 0.1 g is located at the end of the line. An operator places each MUB and reads its weight to verify that it has been filled. The MUB is then sealed, and the corresponding label is affixed. Shipping boxes are also checked in the same way using a QC1500NNP scale (Sartorius ) with 0–1500-kg range and ± 200-g resolution. Shipping boxes are then sealed and labeled accordingly.

Figure 4: Packing-process fault tree showing the branch that follows from product temperature-requirement failure.
This arrangement is designed to ensure good coordination among all operators regarding manual performance. The time each packing operator took to complete an MUB, including visual inspection, was measured as 160–170 s, with a margin of 10 s for recovery. The conveyor was therefore set to a linear velocity of 900 cm/min. The labeling machine had an optimum working speed of 45–47 vials/min. Hence, the buffer operator has an important task, which is to control vial distribution through the conveyor at intervals of 12–13 s. The buffer operator avoids bottlenecks by gathering the overflow of labeled vials to operators, and releasing the collected vials when the labeling machine is interrupted.

Fault-tree analysis of the packing process

Figure 5: Packing-process fault tree showing the branch following from failure in primary-information imprinting.
An FTA model was specially developed for the packing process by representing failure events with logical operators to form a logical information flow chart (see Figure 3). The special symbols employed in this flow chart are explained in the literature (7). The major unwanted event was defined as "Finished-product quality noncompliance resulting from packing process." All cause–effect fault events flow downward. Any of the following failures can provoke the major unwanted event:
  • Failure in product temperature requirements during the packing process (which exclusively applies to products that require refrigeration)
  • Failure of packing material to display the corresponding primary product information (e.g., batch manufacturing date, batch number or identification code, and batch expiration date)
  • Lack of correspondence between product specifications, printed packing material (e.g., vial labels, cartons, leaflets, MUBs, and shipping labels), and documentation (e.g., QA release authorizations, packing order, and records created during packaging)
  • Failure to comply with cleaning and line-clearance requirements for areas involved in the packing process, including labeling machine and all workstations, to avoid product-batch cross contamination.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here